Projects per year
Personal profile
External positions
Associate Professor of Clinical Medicine, Weill Cornell Medical College
Aug 1 2017 → …
Research Area Keywords
- Cancer
- Clinical Care
- Clinical Translation & Trials
Fingerprint
Dive into the research topics where Polly A. Niravath is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Nanotechnology-based targeting of breast cancer liver metastases
Godin, B., Chen, S., Niravath, P. A., Rosato, R. R. & Xu, S.
3/1/21 → 2/28/25
Project: Federal Funding Agencies
-
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer
Sun, K., Xu, Y., Zhang, L., Niravath, P., Darcourt, J., Patel, T., Teh, B. S., Farach, A. M., Guerrero, C., Mathur, S., Sultenfuss, M. A., Gupta, N., Schwartz, M. R., Haley, S. L., Nair, S., Li, X., Nguyen, T. T. A., Butner, J. D., Ensor, J., Mejia, J. A., & 5 others , Oct 14 2022, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 28, 20, p. 4392-4401 10 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations -
Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases
Puri, A., Mylavarapu, C., Xu, J., Patel, T. A., S.Teh, B., Tremont-Lukats, I., Chang, J. C. & Niravath, P., Jun 2022, In: Breast Cancer Research and Treatment. 193, 3, p. 613-623 11 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer
Koca, E., Niravath, P. A., Ensor, J., Patel, T. A., Li, X., Hemati, P., Wong, H., Qian, W., Boone, T., Zhao, J., Ramshesh, P. V., Cohen, A. L., Murthy, A., Nair, S., Darcourt, J. G., Belcheva, A., Kaklamani, V. G. & Chang, J. C. N., Jul 2021, In: Breast Cancer Research and Treatment. 188, 2, p. 433-439 7 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer
Chung, A. W., Anand, K., Anselme, A. C., Chan, A. A., Gupta, N., Venta, L. A., Schwartz, M. R., Qian, W., Xu, Y., Zhang, L., Kuhn, J., Patel, T., Rodriguez, A. A., Belcheva, A., Darcourt, J., Ensor, J., Bernicker, E., Pan, P. Y., Chen, S. H., Lee, D. J., & 2 others , Dec 15 2021, In: Science translational medicine. 13, 624, abj5070.Research output: Contribution to journal › Article › peer-review
53 Scopus citations -
A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer
Anand, K., Niravath, P., Patel, T., Ensor, J., Rodriguez, A., Boone, T., Wong, S. T. & Chang, J. C., Jun 2021, In: Clinical Breast Cancer. 21, 3, p. 199-204 6 p.Research output: Contribution to journal › Article › peer-review
27 Scopus citations